Programme Director Pharmaceutical Industry
AstraZeneca - Pharmaceutical industry, turnover $26Md - 66 000 employees
November 2015
to August 2018
Full-time
Dunkerque
France
- MISSION: managed a pharmaceutical factory extension to double manufacturing capacity for a respiratory medical device, from 20 to 40 M units/year (65 people, €130M Capex).
- ACTIONS: established program governance according to PMO (organization structure, strategy, finances, schedule, deliverables, risks and mitigation plans) - Managed stakeholders (business / finances / engineering / quality) - Member of site leadership team.
- Construction of 2 new production lines (formulation + medical device assembly/packing), a new fully automated warehouse and a new Quality Control laboratory.
- Managed transition to business in order to deliver assets ready to manufacture commercial batches.
- ACHIEVEMENTS: transfer to business completed for the first 3 assets (assembly/packing line in February 2017, Quality Control lab in March 2018, fully automated warehouse in April 2018). Last asset (formulation line) to be transferred to business due end 2018.